Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT: Naltrexone + Bupropion for Methamphetamine Use Disorder
NCT01982643Phase 2Completed
- Start
- Nov 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, bupropion in methamphetamine use disorder (MUD). Started Nov 2013; status: completed.
02
Drugs
naltrexonebupropion
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT01982643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01982643.